These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6282596)

  • 1. Morphine-receptor dissociation constant and the stimulus-effect relation for inhibition of gastrointestinal transit in the rat.
    Raffa RB; Porreca F; Cowan A; Tallarida RJ
    Eur J Pharmacol; 1982 Apr; 79(1-2):11-6. PubMed ID: 6282596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the receptor constants of morphine and ethylketocyclazocine for analgesia and inhibition of gastrointestinal transit in the rat.
    Porreca F; Raffa RB; Cowan A; Tallarida RJ
    Life Sci; 1982 Nov; 31(18):1955-61. PubMed ID: 6294424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The affinity of morphine for its pharmacologic receptor in vivo.
    Tallarida RJ; Cowan A
    J Pharmacol Exp Ther; 1982 Jul; 222(1):198-201. PubMed ID: 6283067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation in vivo of the receptor constants of morphine in naive and morphine-tolerant rats.
    Porreca F; Cowan A; Raffa RB; Tallarida RJ
    Life Sci; 1982 Nov 15-22; 31(20-21):2355-8. PubMed ID: 6298527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites.
    Manara L; Bianchi G; Ferretti P; Tavani A
    J Pharmacol Exp Ther; 1986 Jun; 237(3):945-9. PubMed ID: 3012075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A species difference in the slowing effect of intrathecal morphine on gastrointestinal transit.
    Vaught JL; Cowan A; Gmerek DE
    Eur J Pharmacol; 1983 Oct; 94(1-2):181-4. PubMed ID: 6689154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereospecific opiate receptors in the actions of thyrotropin releasing hormone and morphine on gastrointestinal transit.
    Bhargava HN; Pillai NP
    Life Sci; 1985 Jan; 36(1):83-8. PubMed ID: 2981381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut.
    Bianchi G; Ferretti P; Recchia M; Rocchetti M; Tavani A; Manara L
    Gastroenterology; 1983 Oct; 85(4):852-8. PubMed ID: 6193028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
    Heyman JS; Williams CL; Burks TF; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1988 Apr; 245(1):238-43. PubMed ID: 2834537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
    Tavani A; Petrillo P; La Regina A; Sbacchi M
    J Pharmacol Exp Ther; 1990 Jul; 254(1):91-7. PubMed ID: 2164103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine inhibits gastrointestinal transit in the rat primarily by impairing propulsive activity of the small intestine.
    Fiocchi R; Bianchi G; Petrillo P; Tavani A; Manara L
    Life Sci; 1982 Nov 15-22; 31(20-21):2221-3. PubMed ID: 7162339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.
    Gmerek DE; Cowan A; Woods JH
    J Pharmacol Exp Ther; 1986 Jan; 236(1):8-13. PubMed ID: 3941402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine.
    Bianchi G; Fiocchi R; Peracchia F; Petrillo P; Tavani A; Manara L
    J Pharm Pharmacol; 1984 May; 36(5):326-30. PubMed ID: 6145770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of thyrotropin releasing hormone and morphine on gastrointestinal transit.
    Pillai NP; Bhargava HN
    Peptides; 1984; 5(6):1055-9. PubMed ID: 6099556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism by N-methyl levallorphan-methane sulphonate (SR 58002 C) of morphine-elicited acute and chronic central and peripheral effects.
    Sbacchi M; Colombo M; La Regina A; Petrillo P; Tavani A
    Life Sci; 1988; 42(21):2079-89. PubMed ID: 3386393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal transit following intrathecal or subcutaneous narcotic analgesics.
    Dhasmana KM; Banerjee AK; Erdmann W
    Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):152-61. PubMed ID: 2884939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine no longer blocks gastrointestinal transit but retains antinociceptive action in diallylnormorphine-pretreated rats.
    Tavani A; Bianchi G; Manara L
    Eur J Pharmacol; 1979 Oct; 59(1-2):151-4. PubMed ID: 510395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis toxin modifies the effect of central morphine on rat intestinal motility.
    Parolaro D; Patrini G; Massi P; Parenti M; Rubino T; Giagnoni G; Gori E
    Eur J Pharmacol; 1990 Feb; 177(1-2):75-80. PubMed ID: 2160368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
    Raffa RB; Friderichs E; Reimann W; Shank RP; Codd EE; Vaught JL
    J Pharmacol Exp Ther; 1992 Jan; 260(1):275-85. PubMed ID: 1309873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions.
    Dum JE; Herz A
    Br J Pharmacol; 1981 Nov; 74(3):627-33. PubMed ID: 6271322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.